chr1-15767439-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_017556.4(FBLIM1):c.314C>T(p.Pro105Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000714 in 1,400,440 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_017556.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBLIM1 | NM_017556.4 | c.314C>T | p.Pro105Leu | missense_variant | 4/9 | ENST00000375766.8 | NP_060026.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBLIM1 | ENST00000375766.8 | c.314C>T | p.Pro105Leu | missense_variant | 4/9 | 2 | NM_017556.4 | ENSP00000364921.3 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 3AN: 150202Hom.: 0 Cov.: 25 FAILED QC
GnomAD3 exomes AF: 0.00000458 AC: 1AN: 218234Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 119524
GnomAD4 exome AF: 0.00000714 AC: 10AN: 1400440Hom.: 0 Cov.: 24 AF XY: 0.00000573 AC XY: 4AN XY: 698158
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000200 AC: 3AN: 150202Hom.: 0 Cov.: 25 AF XY: 0.0000273 AC XY: 2AN XY: 73242
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 08, 2024 | The c.314C>T (p.P105L) alteration is located in exon 3 (coding exon 2) of the FBLIM1 gene. This alteration results from a C to T substitution at nucleotide position 314, causing the proline (P) at amino acid position 105 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at